Rakovina Therapeutics Inc.
$138,965.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2022-2023
Canada
Development of in vitro and in vivo assays to evaluate the membrane permeability, bioavailability and pharmacokinetic profiles of a set of anti-cancer agents.